focus -WSS

focus

author：knowledge 2025-09-28 02:48:05 - browse：62836

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Alzheimer's risk factor APOE4 may be a distinct form of the disease

knowledge

WSS

Medicare Advantage 2025 payments will dip, Biden administration says

Insurer loopholes limit power of law against surprise medical bills

Eight reasons why you should get an updated Covid vaccine

First Opinion on colorectal cancer screening: letter and response

Covid silver lining: Unprecedented look at human immune system

A fraught question for the kids of Alzheimer’s: Is it coming for us?

explore

focus

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Better Therapeutics data on benefit with GLP

Medical leaders decry Supreme Court decision on affirmative action

Life sciences deals on track to hit lowest point since 2017

Alkermes shareholders re

People with mental disorders often marry others with same

Hepatitis C has a cure — but many Americans still lack access to it

Researchers CRISPR chickens in bid to protect them from bird flu

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alzheimer's risk factor APOE4 may be a distinct form of the disease

knowledge

Eight reasons why you should get an updated Covid vaccine

How should state employee insurance handle Wegovy?

Harvard scientists, with Google, unveil the most detailed brain map ever

Multiple sclerosis has subtypes with different best treatments: study

Eight reasons why you should get an updated Covid vaccine

Multiple sclerosis has subtypes with different best treatments: study

hotspot

explore

knowledge

entertainment